EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access

SPECT/CT Dosimetry of Bronchial Artery 99m Tc Macroaggregated Albumin Injection in Pulmonary Malignancies: Feasibility Evaluation of Bronchial Artery 90 Y Radioembolization

Eric Wehrenberg-Klee iD, Thomas An, Pedram Heidari iD, Carlos Huesa-Berral iD, Matthew R Dreher, Amanda Eldridge iD, Kirk Fowers, Jan Schuemann, Alejandro Bertolet iD

Radiology · 2025

DOI: 10.1148/radiol.240331 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Radiology, 2025. Verfasst von Eric Wehrenberg-Klee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Interventional Radiology, Department of Radiology, Massachusetts General Hospital, 55 Fruit St, GRB-291, Boston, MA 02114. Hauptthemen laut MEDLINE: Bronchial Arteries, Embolization, Therapeutic, Lung Neoplasms, Single Photon Emission Computed Tomography Computed Tomography. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SPECT/CT dosimetric analysis of technetium 99m macroaggregated albumin injected via the bronchial artery for pulmonary malignancy suggests that bronchial artery yttrium 90 radioembolization could be an alternative treatment for patients unable to receive external beam radiation therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchial ArteriesEmbolization, TherapeuticLung NeoplasmsSingle Photon Emission Computed Tomography Computed TomographyTechnetium Tc 99m Aggregated AlbuminYttrium RadioisotopesAgedFemaleHumansMaleMiddle AgedFeasibility StudiesProspective StudiesRadiometryRadiopharmaceuticals

Substanzen

RadiopharmaceuticalsTechnetium Tc 99m Aggregated AlbuminYttrium RadioisotopesYttrium-90

Autor:innen und Institutionen

  • Division of Interventional Radiology, Department of Radiology, Massachusetts General Hospital, 55 Fruit St, GRB-291, Boston, MA 02114.
  • Division of Nuclear Medicine, Department of Radiology, Massachusetts General Hospital, Boston, Mass.
  • Department of Radiation Oncology, Massachusetts General Hospital, Boston, Mass.
  • Boston Scientific, Marlborough, Mass.

ORCID-Profile: Eric Wehrenberg-Klee, Pedram Heidari, Carlos Huesa-Berral, Amanda Eldridge, Alejandro Bertolet

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Wehrenberg-Klee, E., An, T., Heidari, P., Huesa-Berral, C., Dreher, M. R., Eldridge, A., Fowers, K., Schuemann, J., & Bertolet, A. (2025). SPECT/CT Dosimetry of Bronchial Artery 99m Tc Macroaggregated Albumin Injection in Pulmonary Malignancies: Feasibility Evaluation of Bronchial Artery 90 Y Radioembolization. Radiology. https://doi.org/10.1148/radiol.240331

Vancouver

Wehrenberg-Klee E, An T, Heidari P, Huesa-Berral C, Dreher MR, Eldridge A, et al. SPECT/CT Dosimetry of Bronchial Artery 99m Tc Macroaggregated Albumin Injection in Pulmonary Malignancies: Feasibility Evaluation of Bronchial Artery 90 Y Radioembolization. Radiology. 2025. doi:10.1148/radiol.240331

BibTeX
@article{WehrenbergKlee2025,
  author = {Wehrenberg-Klee, Eric and An, Thomas and Heidari, Pedram and Huesa-Berral, Carlos and Dreher, Matthew R and Eldridge, Amanda and Fowers, Kirk and Schuemann, Jan and Bertolet, Alejandro},
  title = {SPECT/CT Dosimetry of Bronchial Artery 99m Tc Macroaggregated Albumin Injection in Pulmonary Malignancies: Feasibility Evaluation of Bronchial Artery 90 Y Radioembolization},
  journal = {Radiology},
  year = {2025},
  doi = {10.1148/radiol.240331}
}
Kostenlos starten →